Thomas Mitchell Net Worth & Insider Trades

Thomas Mitchell - Director, Neurocrine Biosciences Inc

As of June 24, 2015

What is Thomas Mitchell's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Director, Thomas Mitchell, is estimated to be about $2.57M . Thomas Mitchell owns about 1,000 units of Neurocrine Biosciences Inc common stock. In the last 11 years at Neurocrine Biosciences Inc, Thomas Mitchell has sold an estimated value of $2.75M worth.

What is Thomas Mitchell's Past Insider Trading?

Thomas Mitchell's largest purchase order was 45,000 units , worth over $202.8K on January 15, 2015. Thomas Mitchell's largest sale order was 45,000 units , worth over $1.35M on January 15, 2015. In total, Thomas Mitchell has made about 25 transactions over 11 years of their time at Neurocrine Biosciences Inc. Thomas Mitchell usually trades in May, with the busiest year in 2014 and 2015. The most recent transaction was a sale order of 15,000 units , worth over $740.25K on June 24, 2015.

THOMAS MITCHELL

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Thomas Mitchell's' Mailing Address?

  • Mailing address is 48030 Paso Tiempo Ln La Quinta CA 92253 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on November 10, 2022 by Eric Benevich who sold 24,693 units worth $3.09M . In the last 19 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $367.33M and bought an estimated value of $65.09M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1